Predictive value of extra-prostatic disease detection by pre-operative PSMA-PET for biochemical recurrence-free survival in patients treated with radical prostatectomy: Follow-up analysis of a multicenter prospective phase 3 imaging trial.

Authors

null

Loic Djaileb

UCLA Ahmanson Translational Theranostics Division, Los Angeles, CA

Loic Djaileb , Wesley R Armstrong , Daniel Thompson , Kathleen Nguyen , Andrei Gafita , Andrea Farolfi , Abhejit Rajagopal , Roxanna Juarez , Matthew R. Cooperberg , Peter Carroll , Samuel L. Washington III, Johannes Czernin , Robert Evan Reiter , Thomas A. Hope , Jeremie Calais

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT03368547

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5088)

DOI

10.1200/JCO.2022.40.16_suppl.5088

Abstract #

5088

Poster Bd #

271

Abstract Disclosures